阿替普酶静脉溶栓后替罗非班桥接双重抗血小板聚集治疗内囊预警综合征病例报道 A Case Report of Capsule Warning Syndrome Treated with Tirofiban Bridging Dual Antiplatelet Therapy after Intravenous Thrombolysis with Alteplase

内囊预警综合征(capsule warning syndrome,CWS)是一组罕见的临床症状,具有反复发作刻板样神经功能缺损症状,易进展成完全性卒中的特点。本研究报道1例表现为发作性言语不清伴左侧肢体无力的CWS,该患者经阿替普酶静脉溶栓治疗后24 h内,仍反复发作刻板样言语不清、左侧肢体无力。经评估风险后,静脉溶栓后24 h内予以替罗非班抗血小板聚集治疗,3 d后桥接双重抗血小板聚集治疗,患者未再发作神经功能缺损症状。静脉溶栓治疗后启动抗血小板聚集时机以及抗血小板聚集的方案,仍需大规模数据进一步探讨。 Abstract: Capsule warning syndrome (CWS) is...

Full description

Bibliographic Details
Main Author: 郑剑华,崔燕玲,曹莹,戴建武 (ZHENG Jianhua, CUI Yanling, CAO Ying, DAI Jianwu)
Format: Article
Language:zho
Published: Editorial Department of Chinese Journal of Stroke 2024-03-01
Series:Zhongguo cuzhong zazhi
Subjects:
Online Access:http://www.chinastroke.org.cn/CN/article/openArticlePDF.jsp?id=4002
_version_ 1797244330969137152
author 郑剑华,崔燕玲,曹莹,戴建武 (ZHENG Jianhua, CUI Yanling, CAO Ying, DAI Jianwu)
author_facet 郑剑华,崔燕玲,曹莹,戴建武 (ZHENG Jianhua, CUI Yanling, CAO Ying, DAI Jianwu)
author_sort 郑剑华,崔燕玲,曹莹,戴建武 (ZHENG Jianhua, CUI Yanling, CAO Ying, DAI Jianwu)
collection DOAJ
description 内囊预警综合征(capsule warning syndrome,CWS)是一组罕见的临床症状,具有反复发作刻板样神经功能缺损症状,易进展成完全性卒中的特点。本研究报道1例表现为发作性言语不清伴左侧肢体无力的CWS,该患者经阿替普酶静脉溶栓治疗后24 h内,仍反复发作刻板样言语不清、左侧肢体无力。经评估风险后,静脉溶栓后24 h内予以替罗非班抗血小板聚集治疗,3 d后桥接双重抗血小板聚集治疗,患者未再发作神经功能缺损症状。静脉溶栓治疗后启动抗血小板聚集时机以及抗血小板聚集的方案,仍需大规模数据进一步探讨。 Abstract: Capsule warning syndrome (CWS) is a group of rare clinical symptoms with frequent episodes of stereotyped neurological deficits, and easy progression to complete stroke. This study reported a case of CWS with paroxysmal speech inarticulateness and left limb weakness. Within 24 hours after intravenous thrombolysis with alteplase, the patient still had repeated episodes of stereotypical speech inarticulateness and left limb weakness. After assessing the risk, tirofiban was given within 24 hours after intravenous thrombolysis, and dual antiplatelet therapy was bridged 3 days later. The patient had no recurrence of neurological deficits. However, the timing of initiation of dual antiplatelet therapy after intravenous thrombolysis and the dual antiplatelet therapy program still need large-scale data to further explore.
first_indexed 2024-04-24T19:09:18Z
format Article
id doaj.art-3445162ed124440d974f60571bd61990
institution Directory Open Access Journal
issn 1673-5765
language zho
last_indexed 2024-04-24T19:09:18Z
publishDate 2024-03-01
publisher Editorial Department of Chinese Journal of Stroke
record_format Article
series Zhongguo cuzhong zazhi
spelling doaj.art-3445162ed124440d974f60571bd619902024-03-26T12:32:06ZzhoEditorial Department of Chinese Journal of StrokeZhongguo cuzhong zazhi1673-57652024-03-0119332633010.3969/j.issn.1673-5765.2024.03.011阿替普酶静脉溶栓后替罗非班桥接双重抗血小板聚集治疗内囊预警综合征病例报道 A Case Report of Capsule Warning Syndrome Treated with Tirofiban Bridging Dual Antiplatelet Therapy after Intravenous Thrombolysis with Alteplase郑剑华,崔燕玲,曹莹,戴建武 (ZHENG Jianhua, CUI Yanling, CAO Ying, DAI Jianwu)0郑剑华 1171467118@qq.com (ZHENG Jianhua, E-mail: 1171467118@qq.com)内囊预警综合征(capsule warning syndrome,CWS)是一组罕见的临床症状,具有反复发作刻板样神经功能缺损症状,易进展成完全性卒中的特点。本研究报道1例表现为发作性言语不清伴左侧肢体无力的CWS,该患者经阿替普酶静脉溶栓治疗后24 h内,仍反复发作刻板样言语不清、左侧肢体无力。经评估风险后,静脉溶栓后24 h内予以替罗非班抗血小板聚集治疗,3 d后桥接双重抗血小板聚集治疗,患者未再发作神经功能缺损症状。静脉溶栓治疗后启动抗血小板聚集时机以及抗血小板聚集的方案,仍需大规模数据进一步探讨。 Abstract: Capsule warning syndrome (CWS) is a group of rare clinical symptoms with frequent episodes of stereotyped neurological deficits, and easy progression to complete stroke. This study reported a case of CWS with paroxysmal speech inarticulateness and left limb weakness. Within 24 hours after intravenous thrombolysis with alteplase, the patient still had repeated episodes of stereotypical speech inarticulateness and left limb weakness. After assessing the risk, tirofiban was given within 24 hours after intravenous thrombolysis, and dual antiplatelet therapy was bridged 3 days later. The patient had no recurrence of neurological deficits. However, the timing of initiation of dual antiplatelet therapy after intravenous thrombolysis and the dual antiplatelet therapy program still need large-scale data to further explore.http://www.chinastroke.org.cn/CN/article/openArticlePDF.jsp?id=4002内囊预警综合征阿替普酶静脉溶栓替罗非班阿司匹林氯吡格雷capsule warning syndromealteplaseintravenous thrombolysistirofibanaspirinclopidogrel
spellingShingle 郑剑华,崔燕玲,曹莹,戴建武 (ZHENG Jianhua, CUI Yanling, CAO Ying, DAI Jianwu)
阿替普酶静脉溶栓后替罗非班桥接双重抗血小板聚集治疗内囊预警综合征病例报道 A Case Report of Capsule Warning Syndrome Treated with Tirofiban Bridging Dual Antiplatelet Therapy after Intravenous Thrombolysis with Alteplase
Zhongguo cuzhong zazhi
内囊预警综合征
阿替普酶
静脉溶栓
替罗非班
阿司匹林
氯吡格雷
capsule warning syndrome
alteplase
intravenous thrombolysis
tirofiban
aspirin
clopidogrel
title 阿替普酶静脉溶栓后替罗非班桥接双重抗血小板聚集治疗内囊预警综合征病例报道 A Case Report of Capsule Warning Syndrome Treated with Tirofiban Bridging Dual Antiplatelet Therapy after Intravenous Thrombolysis with Alteplase
title_full 阿替普酶静脉溶栓后替罗非班桥接双重抗血小板聚集治疗内囊预警综合征病例报道 A Case Report of Capsule Warning Syndrome Treated with Tirofiban Bridging Dual Antiplatelet Therapy after Intravenous Thrombolysis with Alteplase
title_fullStr 阿替普酶静脉溶栓后替罗非班桥接双重抗血小板聚集治疗内囊预警综合征病例报道 A Case Report of Capsule Warning Syndrome Treated with Tirofiban Bridging Dual Antiplatelet Therapy after Intravenous Thrombolysis with Alteplase
title_full_unstemmed 阿替普酶静脉溶栓后替罗非班桥接双重抗血小板聚集治疗内囊预警综合征病例报道 A Case Report of Capsule Warning Syndrome Treated with Tirofiban Bridging Dual Antiplatelet Therapy after Intravenous Thrombolysis with Alteplase
title_short 阿替普酶静脉溶栓后替罗非班桥接双重抗血小板聚集治疗内囊预警综合征病例报道 A Case Report of Capsule Warning Syndrome Treated with Tirofiban Bridging Dual Antiplatelet Therapy after Intravenous Thrombolysis with Alteplase
title_sort 阿替普酶静脉溶栓后替罗非班桥接双重抗血小板聚集治疗内囊预警综合征病例报道 a case report of capsule warning syndrome treated with tirofiban bridging dual antiplatelet therapy after intravenous thrombolysis with alteplase
topic 内囊预警综合征
阿替普酶
静脉溶栓
替罗非班
阿司匹林
氯吡格雷
capsule warning syndrome
alteplase
intravenous thrombolysis
tirofiban
aspirin
clopidogrel
url http://www.chinastroke.org.cn/CN/article/openArticlePDF.jsp?id=4002
work_keys_str_mv AT zhèngjiànhuácuīyànlíngcáoyíngdàijiànwǔzhengjianhuacuiyanlingcaoyingdaijianwu ātìpǔméijìngmàiróngshuānhòutìluōfēibānqiáojiēshuāngzhòngkàngxuèxiǎobǎnjùjízhìliáonèinángyùjǐngzōnghézhēngbìnglìbàodàoacasereportofcapsulewarningsyndrometreatedwithtirofibanbridgingdualantiplatelettherapyafterintravenousthrombolysiswithalteplase